Topic List : News Topics
Study of COVID-19 saliva test
An at-home COVID-19 test, designed by Stanford researchers to be easy to use and provide results within 30 minutes, will be the focus of a study funded by the Stanford Medicine Catalyst Program.
Emergency-use authorization for COVID-19 self-test kit
A kit that allows individuals to collect their own nasal swabs and ship the specimens to a lab for COVID-19 testing received an emergency-use authorization from the Food and Drug Administration.
Biomarker for lipedema discovered
Researchers have identified a molecule that ties lipedema to other lymphatic diseases, such as lymphedema, and distinguishes it from obesity.
Eventful first year at new hospital
The 368-bed hospital building, which celebrates its one-year anniversary on Nov. 17, features technology and design features that have made handling COVID-19 cases easier.
Disparities in COVID-19 hospitalizations
Researchers found that Black and Hispanic people made up 58% of all patients hospitalized for COVID-19 and 53% of those who died from the disease.
Flu Crew helps prevent ‘twindemic’
This fall, medical and physician assistant students vaccinated thousands of people against the flu. The vaccinations could help prevent hospitals from being inundated with flu patients if COVID-19 cases surge.
Diversity Week speakers address tough topics
Stanford Medicine community members remotely attended a weeklong series of talks, panels and workshops on reducing disparities and improving diversity in health care and medical education.
How to bounce back from pandemic
Stanford Medicine experts have created a framework to guide public officials, school administrators and business leaders on re-establishing normal operations during and after the COVID-19 pandemic.
Anatomist John Gosling dies at 81
Gosling was the co-author of a popular anatomy textbook and a specialist in the neuroscience of the genitourinary system.
Enrollment for coronavirus vaccine trial
Stanford plans to enroll about 1,000 people as part of a large Phase 3 trial to determine whether a vaccine can protect against infection with the coronavirus.